Fig. 3
BSHLD reduced miR-30a-5p expression in serum, serum-exos and ovarian tissues in PCOS rats. A The microstructure of Exos was observed by TEM. B Nanoparticle Tracking Analysis evaluated the size distribution of Exos. C Western blotting analysis of TSG101, CD63, and calnexin protein levels. D-F Expression of miR-30a-5p in ovarian tissues, serum, and serum-Exos was assessed by RT-qPCR. Results are presented as mean ± SD. n = 10. * p < 0.05, ** p < 0.01, *** p < 0.001